139 related articles for article (PubMed ID: 35131382)
21. Subquinocin, a small molecule inhibitor of CYLD and USP-family deubiquitinating enzymes, promotes NF-κB signaling.
Yamanaka S; Sato Y; Oikawa D; Goto E; Fukai S; Tokunaga F; Takahashi H; Sawasaki T
Biochem Biophys Res Commun; 2020 Mar; 524(1):1-7. PubMed ID: 31898971
[TBL] [Abstract][Full Text] [Related]
22. The inhibition of tumor protein p53 by microRNA-151a-3p induced cell proliferation, migration and invasion in nasopharyngeal carcinoma.
Liu H; Cheng Y; Xu Y; Xu H; Lin Z; Fan J; Lang J
Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31652456
[TBL] [Abstract][Full Text] [Related]
23. Autocrine INSL5 promotes tumor progression and glycolysis via activation of STAT5 signaling.
Li SB; Liu YY; Yuan L; Ji MF; Zhang A; Li HY; Tang LQ; Fang SG; Zhang H; Xing S; Li MZ; Zhong Q; Lin SJ; Liu WL; Huang P; Zeng YX; Zheng YM; Ling ZQ; Sui JH; Zeng MS
EMBO Mol Med; 2020 Sep; 12(9):e12050. PubMed ID: 32657028
[TBL] [Abstract][Full Text] [Related]
24. Loss of the tumor suppressor CYLD enhances Wnt/beta-catenin signaling through K63-linked ubiquitination of Dvl.
Tauriello DV; Haegebarth A; Kuper I; Edelmann MJ; Henraat M; Canninga-van Dijk MR; Kessler BM; Clevers H; Maurice MM
Mol Cell; 2010 Mar; 37(5):607-19. PubMed ID: 20227366
[TBL] [Abstract][Full Text] [Related]
25. Loss of Tumor Suppressor CYLD Expression Triggers Cisplatin Resistance in Oral Squamous Cell Carcinoma.
Suenaga N; Kuramitsu M; Komure K; Kanemaru A; Takano K; Ozeki K; Nishimura Y; Yoshida R; Nakayama H; Shinriki S; Saito H; Jono H
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31635163
[TBL] [Abstract][Full Text] [Related]
26. Deubiquitinating enzyme CYLD regulates the peripheral development and naive phenotype maintenance of B cells.
Jin W; Reiley WR; Lee AJ; Wright A; Wu X; Zhang M; Sun SC
J Biol Chem; 2007 May; 282(21):15884-93. PubMed ID: 17392286
[TBL] [Abstract][Full Text] [Related]
27. LPLUNC1 stabilises PHB1 by counteracting TRIM21-mediated ubiquitination to inhibit NF-κB activity in nasopharyngeal carcinoma.
Wang H; Zhou Y; Oyang L; Han Y; Xia L; Lin J; Tang Y; Su M; Tan S; Tian Y; Chen X; Luo X; Liang J; Rao S; Wang Y; Xiong W; Zeng Z; Wang H; Li G; Liao Q
Oncogene; 2019 Jun; 38(25):5062-5075. PubMed ID: 30886235
[TBL] [Abstract][Full Text] [Related]
28. IKBB tumor suppressive role in nasopharyngeal carcinoma via NF-κB-mediated signalling.
Phoon YP; Cheung AK; Cheung FM; Chan KF; Wong S; Wong BW; Tung SY; Yau CC; Ng WT; Lung ML
Int J Cancer; 2016 Jan; 138(1):160-70. PubMed ID: 26227166
[TBL] [Abstract][Full Text] [Related]
29. TRIM15 and CYLD regulate ERK activation via lysine-63-linked polyubiquitination.
Zhu G; Herlyn M; Yang X
Nat Cell Biol; 2021 Sep; 23(9):978-991. PubMed ID: 34497368
[TBL] [Abstract][Full Text] [Related]
30. Potential role of CYLD (Cylindromatosis) as a deubiquitinating enzyme in vascular cells.
Takami Y; Nakagami H; Morishita R; Katsuya T; Hayashi H; Mori M; Koriyama H; Baba Y; Yasuda O; Rakugi H; Ogihara T; Kaneda Y
Am J Pathol; 2008 Mar; 172(3):818-29. PubMed ID: 18245814
[TBL] [Abstract][Full Text] [Related]
31. FOXA1 reprograms the TGF-β-stimulated transcriptional program from a metastasis promoter to a tumor suppressor in nasopharyngeal carcinoma.
Li J; Wang W; Chen S; Cai J; Ban Y; Peng Q; Zhou Y; Zeng Z; Li X; Xiong W; Li G; Yi M; Xiang B
Cancer Lett; 2019 Feb; 442():1-14. PubMed ID: 30392786
[TBL] [Abstract][Full Text] [Related]
32. CYLD Regulates Centriolar Satellites Proteostasis by Counteracting the E3 Ligase MIB1.
Douanne T; André-Grégoire G; Thys A; Trillet K; Gavard J; Bidère N
Cell Rep; 2019 May; 27(6):1657-1665.e4. PubMed ID: 31067453
[TBL] [Abstract][Full Text] [Related]
33. Methylation-associated silencing of miR-9-1 promotes nasopharyngeal carcinoma progression and glycolysis via HK2.
Xu QL; Luo Z; Zhang B; Qin GJ; Zhang RY; Kong XY; Tang HY; Jiang W
Cancer Sci; 2021 Oct; 112(10):4127-4138. PubMed ID: 34382305
[TBL] [Abstract][Full Text] [Related]
34. CircZNF609 promotes cell proliferation, migration, invasion, and glycolysis in nasopharyngeal carcinoma through regulating HRAS via miR-338-3p.
Liu Z; Liu F; Wang F; Yang X; Guo W
Mol Cell Biochem; 2021 Jan; 476(1):175-186. PubMed ID: 32970285
[TBL] [Abstract][Full Text] [Related]
35. Downregulation of miR-204 facilitates the progression of nasopharyngeal carcinoma by targeting CXCR4 through NF-κB signaling pathway.
Zong G; Han J; Yue Z; Liu Y; Cui Z; Shi L
J BUON; 2020; 25(2):1098-1104. PubMed ID: 32521912
[TBL] [Abstract][Full Text] [Related]
36. A positive feedback loop between LINC01605 and NF-κB pathway promotes tumor growth in nasopharyngeal carcinoma.
Zhao W; Xin L; Tang L; Li Y; Li X; Liu R
RNA Biol; 2022; 19(1):482-495. PubMed ID: 35373703
[TBL] [Abstract][Full Text] [Related]
37. An integrative transcriptomic analysis reveals p53 regulated miRNA, mRNA, and lncRNA networks in nasopharyngeal carcinoma.
Gong Z; Yang Q; Zeng Z; Zhang W; Li X; Zu X; Deng H; Chen P; Liao Q; Xiang B; Zhou M; Li X; Li Y; Xiong W; Li G
Tumour Biol; 2016 Mar; 37(3):3683-95. PubMed ID: 26462838
[TBL] [Abstract][Full Text] [Related]
38. JMJD2A promotes the Warburg effect and nasopharyngeal carcinoma progression by transactivating LDHA expression.
Su Y; Yu QH; Wang XY; Yu LP; Wang ZF; Cao YC; Li JD
BMC Cancer; 2017 Jul; 17(1):477. PubMed ID: 28693517
[TBL] [Abstract][Full Text] [Related]
39. LRRC62 attenuates Toll-like receptor signaling by deubiquitinating TAK1 via CYLD.
Zhang J; Ou J; Wan X
Exp Cell Res; 2019 Oct; 383(1):111497. PubMed ID: 31301291
[TBL] [Abstract][Full Text] [Related]
40. [Expressions of p53 pathway genes and EZH2 in undifferentiated nasopharyngeal carcinoma].
Liu XD; Ji MF
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jun; 31(6):1029-33. PubMed ID: 21690062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
